GNR-084

· AO GENERIUM

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GNR-084, covering 2024-03-06 to 2024-03-06. Get the full timeline:

Most recent: Clinical Trial Update: GNR-084 Safety and Pharmacological Characteristics in Refractory or Relapse B-cell Precursor ALL [Phase 1, Phase 2]

See pricing